Elanco Animal Health Incorporated
ELAN
$10.35
-$0.15-1.43%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 127.46% | 117.92% | -1,010.62% | -4,907.69% | -1,478.21% |
Total Depreciation and Amortization | -2.81% | -1.76% | -0.32% | 3.09% | 3.73% |
Total Amortization of Deferred Charges | -25.93% | -16.92% | -16.92% | -16.92% | -16.92% |
Total Other Non-Cash Items | -154.87% | -153.67% | 1,056.70% | 275.79% | 257.42% |
Change in Net Operating Assets | 149.67% | 145.70% | 103.27% | 93.32% | 35.06% |
Cash from Operations | 99.63% | 310.24% | 372.03% | 13.28% | -40.04% |
Capital Expenditure | -5.00% | 19.89% | 26.26% | 20.45% | 18.13% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -115.79% | 73.68% | 50.00% | 50.00% | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -40.00% | 93.33% | 143.75% | 138.46% | -25.00% |
Cash from Investing | 785.21% | 677.62% | 68.25% | 62.44% | 5.59% |
Total Debt Issued | -5.00% | -5.00% | 128.00% | -55.56% | -39.27% |
Total Debt Repaid | -202.07% | -244.46% | -257.93% | 39.39% | 55.02% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -183.33% | -360.00% | 15.79% | 53.57% | 81.25% |
Cash from Financing | -1,697.59% | -5,610.71% | -940.00% | -62.29% | 84.88% |
Foreign Exchange rate Adjustments | -658.33% | -170.00% | -257.14% | -130.77% | 29.41% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1,557.14% | 232.97% | 135.00% | 212.50% | 102.39% |